11158424

Insulin Management

PublishedOctober 26, 2021
Assigneenot available in USPTO data we have
Technical Abstract

Patent Claims
9 claims

Legal claims defining the scope of protection, as filed with the USPTO.

1

1. A system comprising: data processing hardware; and memory hardware in communication with the data processing hardware and storing instructions that when executed on the data processing hardware cause the data processing hardware to perform operations comprising: receiving a glucose measurement of a patient on a current day; determining a glucose type of the received glucose measurement; when the determined glucose type comprises a pre-breakfast glucose measurement: obtaining a previous Carbohydrate-to-Insulin Ratio (CIR) for an immediately previous dinner meal consumed by the patient on a day immediately preceding the current day; obtaining a previous bedtime glucose measurement of the patient on the day immediately preceding the current day; adjusting the previous CIR for the immediately previous dinner meal consumed by the patient based on the obtained previous bedtime glucose measurement; and determining a recommended breakfast bolus based on the adjusted previous CIR; and transmitting to a patient device remotely located from the data processing hardware and in communication with the data processing hardware via a network, the recommended breakfast bolus at the time of day associated with the determined glucose type, the recommended breakfast bolus when received by the patient device causing the patient device to display a number of units of insulin for the patient to administer using the recommended breakfast bolus.

2

2. The system of claim 1 , wherein adjusting the previous CIR for the immediately previous dinner meal consumed by the patient comprises: determining an adjustment factor based on the obtained previous bedtime blucose measurement; and adjusting the previous CIR for the immediately previous dinner meal consumed by the patient by dividing the previous CIR by the adjustment factor.

3

3. The system of claim 2 , wherein determining the adjustment factor comprises: determining whether the obtained previous bedtime glucose measurement is within one of a plurality of target ranges of values; and when the obtained previous bedtime glucose measurement is within one of the plurality of target ranges of values, setting the adjustment factor to a target adjustment factor associated with the corresponding target range of values that includes the obtained previous bedtime glucose measurement.

4

4. The system of claim 1 , wherein determining the recommended breakfast bolus comprises: receiving a number of carbohydrates to be consumed by the patient for breakfast; and dividing the received number of carbohydrates by the adjusted previous CIR.

6

6. The system of claim 1 , wherein the operations further comprise: selecting a governing glucose measurement as a lesser one of a previous midsleep glucose measurement or the pre-breakfast glucose measurement; determining a basal adjustment factor for adjusting a current day's recommended basal dose based on the selected governing glucose measurement; obtaining a previous day's recommended basal dose; and determining the current day's recommended basal dose by multiplying the adjustment factor times the previous day's bedtime recommended basal dose.

7

7. The system of claim 6 , wherein the current day's recommended basal dose corresponds to an insulin dose of long-acting insulin to be administered to the patient at a configurable frequency of one, two, or three times per day.

8

8. The system of claim 1 , wherein receiving the glucose measurement of the patient comprises receiving the glucose measurement from a continuous glucose monitoring system associated with the patient.

9

9. The system of claim 1 , wherein receiving the glucose measurement of the patient comprises receiving the glucose measurement from a glucometer associated with the patient.

10

10. The system of claim 1 , wherein the recommended breakfast bolus corresponds to an insulin dose of rapid-acting insulin to be administered to the patient at the time of day associated with the determined glucose type to bring and maintain the patient's glucose level into a target range.

Patent Metadata

Filing Date

Unknown

Publication Date

October 26, 2021

Inventors

Robert C. Booth
Harry Hebblewhite

Want to explore more patents?

Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.

Citation & reuse

Analysis on this page is generated by Patentable — an AI-powered patent intelligence platform. AI-generated summaries, explanations, and analysis may be reused with attribution and a visible link back to the canonical URL below. Patent abstracts and claims are USPTO public domain.

Cite as: Patentable. “Insulin Management” (11158424). https://patentable.app/patents/11158424

© 2026 Patentable. All rights reserved.

Patentable is a research and drafting-assistant tool, not a law firm, and does not provide legal advice. Documents we generate are drafts for review by a licensed patent attorney.